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ABSTRACT
Objective: This study is aimed to evaluate the antioxidant (AO) potential, cytotoxicity, and stability of preformulated Ginkgo biloba standard extract 
microemulsion (GBME), to investigate if, it retains the therapeutic potential of EGB761 and remains safe and stable for a longer period.
Method and Results: GBME has shown enhanced AO (85.2±0.78%, IC50=31.3±0.45 µg/ml) in comparison to EGB761 (74.1±0.51%, 
IC50=49.4±0.05 µg/ml) using 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) assay. Similarly, 2,2-diphenyl-1-picryl-hydrazyl-hydrate 
(DPPH) assay has also shown that AO for GBME (94.6±0.04%, IC50=11.4±1.03 µg/ml) was higher than EGB761 (78.6±1.20%, IC50=34.6±0.81 µg/ml). 
Further, IC50 value of antiradical unit of GBME was much lesser (ABTS=14.3±1.05 µg/ml and DPPH=17.03±1.8 µg/ml) in comparison to EGB761 
(ABTS=34.1±1.62 µg/ml and DPPH=37.5±0.08 µg/ml). Equivalently, both, hydrogen peroxide scavenging activity, and nitric oxide activity were 
appreciably higher for GBME than the pure extract. The in vitro cytotoxicity assessment showed that GBME is quite safe (98.68±0.76% cell viability) in 
comparison to EGB761 (83.29±1.02%). Thereafter, these samples were tested for stability by evaluating their AO activity along with high-performance 
liquid chromatography analysis, for the major phytocompounds, after 1 year, and results suggested that AO of GBME remained stable while comparing 
with the freshly prepared GBME, whereas AO of EGB761 reduced significantly as compared to freshly taken EGB761 extract implying the degradation 
of phytocompounds supporting decrease in AO activity.
Conclusion: Therefore, the observed results suggest that GBME maintained AO and scavenging activity along with enhanced shelf life with no observed 
toxicity, which can be explored further for its potential therapeutic implications in various oxidative stress-induced central nervous system disorders.
Keywords: Phytoconstituents, Flavonoid, Nitric oxide, 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) assay, radical scavenging activity, 
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide assay.
INTRODUCTION
Medicinal plants are the most opulent resource of bioactive compounds 
that have a wide application in various diseases. Around 80% of the 
world population is dependent on herbal medicines for their therapeutic 
benefits but on the contrary, very limited numbers of phytocompounds 
are approved by governing and regulatory authority’s worldwide [1,2]. 
Treating central nervous system (CNS) ailments has been a challenging 
task due to various unavoidable physiological limitations [3]. There 
are various biological barriers such as blood brain barrier and blood-
cerebrospinal fluid barrier which obstruct the drug distribution toward 
the targeted sites of brain thereby, prohibiting the passive diffusion of 
several compounds into the CNS [4]. One of the important pathological 
mechanisms leading to the various CNS disorders is generation of 
reactive oxygen species (ROS) [5]. Although the molecular form of 
oxygen is an essential component for the survival of living forms, its 
other forms such as superoxide ion can cause internal cell damage 
due to their oxidative properties [6]. Similarly, many biological and 
physiological processes in human body also cause production of ROS 
and free radicals as residual products. Many of these species are neutral 
but are unstable as they carry unpaired electrons and to attain stability; 
they pair themselves with other odd or unpaired electrons [7]. When 
these species are released in excess, they eventually cause oxidative 
stress, leading to structural and functional damage to essential 
biomolecules of body [8]. Therefore, these free radicals are reported 
to start the chain reactions, finally causing the diseased conditions due 
to initiation of apoptotic and other changes [9,10]. Various medicinal 
and herbal plants are being used as remedies to overcome such 
irregularities. Ginkgo biloba is reported to be a potential tree for the 
treatment and improvement of various neuronal disorders such as 
dementia, multiple sclerosis, Alzheimer’s disease, tinnitus, and other 
cognitive impairments due to its polyvalent therapeutic actions [11]. 
It has been traditionally popular in China [12] and had also been 
extensively used as a nutraceutical and therapeutic drug compound 
in Europe and South Asian countries [13]. The standard extract of 
G. biloba (EGB761) is reported to have many important flavonoids such 
as quercetin-3-β-D-glucoside, quercitrin, rutin, quercetin, kaempferol, 
and isorhamnetin and terpene lactone components (ginkgolide A, B, C, 
bilobalide and Ginkgo toxin). It also includes 24% flavone glycosides 
and 6% terpenes (ginkgolides A, B, C, and bilobalide) [14,15].
The current research trends in pharmaceutical industries exhibit the 
preference of phytocompounds over the chemically fabricated drugs 
due to their comparatively higher patient compliance, with less side 
effects [16]. Standardized extract of G. biloba, has higher content of 
potential compounds such as flavonoids, polyphenols, and terpenoids, 
but these compounds are not very stable and get degraded easily in gut 
and other tissue fluids and also have shorter shelf life [17]. There are 
various other factors which lead to their low bioavailability, bioefficacy, 
permeability, and poor stability [18]. Therefore, more effective and 
stable delivery system is required to enhance their therapeutic index. 
Microemulsions (ME) are a viable system to eliminate the degradation 
hydrolysis and oxidation of the phytocompounds [19]. Hence, this 
study is primarily focused on comparing the antioxidant (AO) along 
with stability and cytotoxicity assessment of previously formulated 
GBME with the pure EGB761 extract, to evaluate if the developed ME 
system could enhance the bioavailability, therapeutic index, stability 
with longer shelf life.
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2017.v10i8.19537
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METHODS
The standardized EGB761 was obtained from the Ranbaxy Research 
Laboratory, India, as a gift sample, potassium persulfate (K2O8S2), 
ascorbic acid (AA), phosphomolybdate reagent, gallic acid, sodium 
nitroprusside, Folin–Ciocalteu, aluminum chloride were procured from 
High Media Laboratories, Mumbai, Maharashtra, India, and all other 
chemicals used were of analytical grade.
Preparation of GBME
The EGB761 extract loaded oil in water (o/w) ME system was prepared 
by water titration method as published before [20]. Where, isopropyl 
myristate, tween 80, and ethanol were selected as oil, surfactant, and 
cosurfactant phases, respectively, along with water as aqueous phase. 
In addition, the stabilization of prepared ME formulation is equally 
essential and it is usually balanced by Smix (surfactants and cosurfactants) 
components present in the colloidal system which equilibrates the 
interfacial tension between the oil droplets and aqueous phases [21], 
within the generally regarded as safe (GRAS) limits, thus all the 
excipients used in the formulation followed the criteria. The optimized 
formulation after approving their thermodynamic stability was further 
characterized by particle size, polydispersity index, zeta potential, 
transmission electron microscopy, Fourier transform infrared, and 
rheological studies analysis were accompanied by in vitro permeability 
kinetics [20].
In vitro studies – AO assays
Radical scavenging assays (2,2’-azino-bis(3-ethylbenzothiazoline-
6-sulfonic acid) [ABTS] and 2,2-diphenyl-1-picryl-hydrazyl-
hydrate [DPPH])
The AO potential and antiradical unit (AU) activity of EGB761 and 
GBME were estimated by both ABTS and DPPH assays [22].
As discussed by Re et al. (1999) [23] in case of ABTS assay, which is 
based on the ability of test samples to scavenge the radical cations 
and inhibit the oxidation of ABTS. These radicals were produced in 
response to the reaction between ABTS (7 mM) solution in water with 
potassium persulfate (K2O8S2) (2.45 mM). The reaction mixture (500 µl 
of ABTS added with equal amount of K2O8S2) was left for 16 hrs in the 
dark at 37°C and then diluted further with 27 ml of distilled water. 
Consequently, the DPPH assay which is widely used for analyzing AO 
activity of plant extracts specifically was also performed [24]. In this 
assay, reduction in the rate of chemical reaction absorption spectra was 
reflected by change of deep violet color in solution to pale yellow, after 
adding DPPH solution [25].
After this, in 20 µl of test samples (EGB761 and GBME) (10-100 µg/ml), 
980 µl of ABTS/DPPH reagent was mixed and stirred continuously 
(120 seconds) and incubated again for 30 minutes. Then absorbance 
was taken at 734 nm and 520 nm, respectively to estimate for scavenging 
effect of the same.
Furthermore, reduction in ABTS and DPPH free radicals due to the 
antiradical compounds (EGB761 and GBME) was estimated further at 
the above-mentioned wavelengths [26,27]. AA (10-50 µg/ml) was used 








( )( )= − ×100
Where, AOC and AOT are the absorbance of control and test samples, 
respectively.
Whereas, amount of AUs (AU734 and AU520) present in the tests 
compounds were estimated as [29]:
AU734 = (AR0−AR1)−(ARC0−ARC1) (1)
AU520 = (AR0−AR1)−(ARC0−ARC1) (2)
Where, AR0 is the absorbance recorded for the test samples at the onset 
of reaction (0 seconds), and AR1 is the readings of the same samples 
taken after incubation time (30 minutes) of the reaction. While ARC0 
represents the absorbance shown by control sample at the beginning 
of reaction and ARC1 is the absorbance taken after 30 minutes of the 
same [30]. Now, since ARC0−ARC1 was always invariably equivalent to 0 
hence, above equation can be reduced down to the following:
AU734 = (AR0−AR1) (3)
AU520 = (AR0−AR1) (4)
The IC50 values of the experimental models were also assessed to find 
out, the concentration of test samples that has inhibited 50% of the free 
radicals [31].
Hydrogen peroxide scavenging activity
Hydrogen peroxide is comparatively a very mild oxidant, present 
in phagosomes but due to its oxidizing behavior, it inactivates 
few enzymes such as human myeloperoxidase (MPO) and protein 
tyrosine phosphatases [32] and may alter many amino acids of 
protein structure by cleaving the peptidic bond, hence causing 
biocatalysis in cellular structures [33]. Therefore, to reduce down 
the excessive accumulation and toxic effects of H2O2 many AO 
phytocompounds are considered to be effective. Similarly, in this 
experiment, the capacity of G. biloba (EGB761) extract and its ME 
(GBME) were analyzed to scavenge the hydrogen peroxide by the 
method of Keser et al. (2012) [34]. In each aliquot (0.1 ml) of the 
experimental solutions (EGB761 and GBME) which were taken in 
different concentrations (10-100 µg/ml), 50 mM phosphate buffer 
(pH 7.4) was added and final volume was made up to 0.4 ml. Further, 
to this 0.6 ml of hydrogen peroxide solution was added and incubated 
for 10 minutes; finally, absorbance was recorded at 230 nm [35]. The 
hydrogen peroxide scavenging activity of both was calculated and 
compared by AA which was used as a reference compound, by using 
following equation:
H O activity %
Control absorbance  Sample absorbance
C




Nitric oxide (NO) scavenging activity
NO is an essential biomolecule which controls and regulates various 
physiological mechanisms in human body such as transduction and 
propagation of neural signaling, regularizing the systemic circulation, 
antimicrobial and anticancerous activities but, when it reacts 
with free radicals, it develops peroxy nitrite anion (ONOO-) [36]. 
Therefore, we aimed to estimate the NO radical quenching ability 
of standard Ginkgo biloba (EGB761) along with its microemulsions 
(GBME), taking AA as a standard by spectrophotometric 
quantification. For this, 0.5 ml of 10 mM sodium nitroprusside 
(dissolved in PBS, pH 7.2) was added in 1 ml of test samples (EGB761 
extract and GBME) taken at different concentrations (10-100 µg/ml) 
and incubated at 25°C for 3 hrs. After this 1 ml of Griess reagent is 
added and the absorbance of purple colored chromophore coupled 
with naphthyl ethylenediamine dihydrochloride was recorded at 
546 nm [37], this complex developed due to the diazotization of 
nitrite with sulphanilamide. Then, % of inhibition was calculated by 




 = − ×0 1
0
100
Where, I0 = Absorbance of control and I1 = Absorbance of test samples.
All the experiments were performed in triplicates, and the results are 
expressed as an average of all the independent determinations.
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In vitro cytotoxicity studies: 3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyl tetrazolium bromide (MTT) assay
The cytotoxicity of GBME was assessed on Vero cell line through the 
MTT colorimetric assay [39]. The cells were maintained in DMEM 
medium supplemented with 100 IU/ml penicillin, 100 µg/ml 
streptomycin, and 10% fetal bovine serum in humidified atmosphere 
of 5% CO2 at 37°C to get adhered. The cells were trypsinized and 
seeded in triplicates at the concentration of 5.0×105 cells/ml in 96 well 
tissue culture plates. Thereafter, the cells were treated with different 
concentrations (10-100 µg/ml) of test samples (EGB761 and GBME) for 
6 and 12 hrs individually, in each well. Subsequent to the incubation 
20 µl of MTT solution (5 mg/ml) was added to the respective wells 
and incubated again for 4 hrs, the viable cells converted the yellow dye 
MTT to formazan crystals, which were dissolved in 200 µl of dimethyl 
sulfoxide and the optical density was determined by microplate reader 
at 570 nm [40].
Stability testing of GBME and EGB761 extract
The stability of test samples was evaluated by the method reported 
by Basheer et al., 2013 [41]. In this assay, the stability of EGB761 and 
GBME in various concentrations (10-100 µg/ml) was tested, in terms 
of their AO activity (ABTS and DPPH radical scavenging) after storing 
them to room temperature (37°C) for 1 year and then comparing it 
with the AO of the fresh samples. The optimized and final formulation 
encapsulating the EGB761 extract was analyzed and quantified by 
using reversed phase, high-performance liquid chromatography 
(HPLC) (Waters) method [42] to evaluate the stability of important 
AO components (Quercetin, Isorhamnetine, and Kaempferol) after 
storing them for 1 year. The chromatographic analysis was done on C18 
column with detection at 370 nm, and temperature was fixed at 35°C. 
A stock solution (10 mg/ml, with respect to extract present) of GBME 
was prepared in mobile phase with subsequent dilutions (2-10 mg/ml). 
The isocratic mobile phase for HPLC was consisted of methanol and 
phosphoric acid (0.3%) in equivalent ratio (50:50), which was degassed 
by passing through a 0.45 µm Millipore filter and sonicated for 
10 minutes and pumped at a flow rate of 1 ml/minute [43,44].
RESULT AND DISCUSSIONS
Preparation of GBME
The GBME formulation was developed earlier [20] (particle size 
of 259.8±6.3 nm, PDI score of 0.186±0.092 and zeta potential as 
−9.87±2.23 mv) using isopropyl mystriate, tween 80, and ethanol as, 
oil, surfactant, and cosurfactant phases, respectively. Surfactant and 
cosurfactant components are very important in ME formulation as 
they reduce down the interfacial tension between the 2 phases (oil 
and water) [45]. In the present study, tween 80 which is a nonionic, 
hydrophilic surfactant, composed of same polar heads but different 
lipophilic tails are reported to have highest solubilization capacity, 
lowest toxicity and irritability properties, aiding in enhancing the 
therapeutic efficiency of GBME along with short chain alkanol (ethanol), 
which is known for improving the ME formulation by affecting the 
interfacial energy, when it interacts with surfactant monolayers [46].
Radical scavenging assays (ABTS and DPPH)
The measurement of AO activity through ABTS assay for EGB761 
extract and GBME showed the higher AO activity of GBME 
(89.2±0.78%) in comparison to EGB761 (74.1±0.51%) at the highest 
concentration (100 µg/ml) (Fig. 1a). Consequently, the IC50 value of 
GBME was also noted significantly lesser (29.6±0.03 µg/ml) than 
the EGB761 (47.1±0.32 µg/ml) (Fig. 1a). Similarly, in case of DPPH 
estimation, AO activity of GBME (94.6±0.04%) was again recorded 
to be higher than EGB761 (77.6±1.20%), and IC50 value for GBME 
was estimated to be distinctly lower (12.8±0.55 µg/ml) than 
EGB761 (31.1±0.81 µg/ml) hence, reflecting more effective activity of 
GBME at lower concentrations too (Fig. 1b). Their IC50 value during 
ABTS assay gives an insight that GBME with all its components has 
equally comparable AO as the standard (AA) alone. Initially, it was 
observed that AO activity of GBME was recorded lower (17.6±1.6%) 
as compared to EGB761 (22.61±0.82%) at 10 µg/ml, as suggested by 
Koga et al., 2011 [47] this phenomenon may arise due to some of the 
phytocompounds getting partitioned into the oil phase and it took 
some time by them to partition out from the oil phase into the external 
medium. Later it was observed that, with the increase in concentrations, 
GBME exhibited fairly better activity than the extract. As, DPPH is highly 
sensitive toward even the weakest AOs and can very well analyze both 
hydrophilic and lipophilic components thus, in DPPH assay GBME, at its 
lowest concentration of 10 µg/ml also recorded higher (46.4±1.6%) AO 
activity than extract (33.17±1.8%) as represented in Fig. 1a and b. The 
reason for enhanced activity may be contributed by the components 
of the ME including extract as well as surfactant cosurfactants of the 
carrier system (ABTS=35.4±0.27% and DPPH=43.2±1.0%).
Antiradical action of pure extract (EGB761), ME without extract and 
GBME in existence of ABTS as a source of radical enhancer (Table 1) 
was also compared with standard (AA). The IC50 values of all the test 
samples (AA, EGB761and GBME) were calculated and it was being 
observed that EGB761 showed the highest IC50 value (34.6±0.81 µg/ml), 
whereas IC50 value of GBME (12.8±0.55 µg/ml) (Table 2) was slightly 
higher than the standard (AA=11.2±0.26 µg/ml), (p<0.5) suggesting the 
enhanced scavenging activity even at lower concentration.
Hydrogen peroxide scavenging activity
Hydrogen peroxide as mentioned above is known to be a weak 
oxidizing agent, and when it gets reacted with Fe2+ or Cu2+ complexes 
inside the cells, it forms highly reactive hydroxyl radicals which lead 
to its detrimental effects [46]. Hydrogen peroxide scavenging ability 
of both the test samples (EGB761 and GBME) was found to be dose 
dependent as it increases with the increase in concentrations of test 
samples (Fig. 2). IC50 value for GBME and EGB761 were found to be 
18.4±1.06 µg/ml and 42.8±0.45 µg/ml, respectively, in comparison to 
Fig. 1: (a) Antioxidant (AO) activity (%) against 2,2’-azino-bis(3-
ethylbenzothiazoline-6-sulphonic acid) of EGB761 and GBME 
with IC50 values. (b) AO activity (%) against 2,2-diphenyl-1-
picryl-hydrazyl-hydrate assay of EGB761 and GBME with IC50 
values. EGB761: Purified standard extract of Gingko biloba, 
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the standard (AA) which was 12.5±0.83, reflecting the fact that GBME 
has almost equivalent quenching ability as that of, standard and better 
than the pure extract. This improved characteristic of GBME can be 
attributed to the combination of the retained phenolic and flavonoid 
contents of extract along with the ME excipients [47]. Hence, from the 
results obtained, we can sequence the scavenging activity of hydrogen 
peroxide of various test samples as AA>GBME>EGB761.
NO scavenging activity
The percentage inhibition of NO free radical was plotted against various 
concentrations (10-100 µg/ml) of test samples (EGB761 and GBME) 
as represented in Fig. 3. GBME showed % inhibition of 93.1±1.72% at 
its highest concentration of 100 µg/ml, whereas the % inhibition for 
standard (AA) was found to be 97.43±1.23% and EGB761=88.2±1.6% 
on the same concentration. Furthermore, it can be concluded from the 
represented result data of dose-response curve that both of the test 
samples are concentration dependent. Hence, exhibiting the enhanced 
scavenging potential of GBME than EGB761 and ME without extract.
In vitro cytotoxicity studies: MTT assay
Cytotoxicity of mentioned test samples was tested on Vero cell line, 
using MTT assay. The results show (Fig. 4) that pure extract is more 
toxic (63.14±0.72% cell viability) than GBME (80.62±1.05% cell 
viability) at its highest concentrations (100 µg/ml). Results also 
showed a very low cytotoxic effect (95.2±0.42%) of the ME system 
(only ME with no extract loading) indicating the nontoxic nature of the 
excipients used for the ME system (Fig. 5). These results were expected 
as the excipients selected for the formulation (ME) were within the 
GRAS limits. However, the label claim for the GBME is 60 µg/ml, and till 
this range, no significant cellular toxicity was observed.
Stability testing of GBME and EGB761 extract
Stability of the test samples was checked after storing them at room 
temperature (37°C) for 12 months and testing the retention ability of 
their AO content left after storing them for mentioned time by the same 
methods: ABTS and DPPH assay. It was being observed that EGB761 had 
shown a significance loss of AO in comparison to GBME (85.8±0.49% vs. 
68.7±1.41% AO activity) in case of ABTS assay. Similarly, through DPPH 
assay analysis also, EGB761 reflected a prominent loss and degradation 
of therapeutic phytocompounds with loss of AO activity of 65.2±1.06% 
in comparison to GBME (90.11±1.2%). As mentioned before the 
freshly prepared samples had higher AO of GBME (ABTS=89.2±0.78% 
and DPPH=94.6±0.04%) than EGB761 (ABTS=74.1±0.51%, 
DPPH=77.6±1.20%). Therefore, from this comparative data, we can 
conclude that ME system has enhanced the stability and shelf life of the 
Fig. 2: Graph depicting H2O2 scavenging activity (%) 
of ME, EGB761, and GBME at different concentrations. 
ME: Microemulsion without EGB761, GBME: EGB761 loaded 
microemulsion, EGB761: Extract of Gingko biloba
Fig. 3: Graph depicting nitric oxide scavenging activity 
(%) of ME, EGB761 and GBME at different concentrations. 
ME: Microemulsion without EGB761, GBME: EGB761 loaded 
microemulsion, EGB761: Extract of Gingko biloba
Fig. 4: In vitro cytotoxicity analysis of the optimized EGB761, 
ME and GBME at various concentrations (10-100 µg/ml) after 
12 hrs of treatment by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl 
tetrazolium bromide assay. ME: Microemulsion without extract, 
GBME: EGB761 loaded microemulsion, EGB761: Purified extract 
of Gingko biloba
Table 1: AU in ABTS and DPPH assay against EGB761 and GBME 




AU ‑ ABTS method AU - DPPH method
EGB761 GBME EGB761 GBME
10 0.141±0.02 0.296±0.05 0.221±0.02 0.395±0.006
20 0.238±0.01 0.254±0.01 0.356±0.004 0.570±0.09
40 0.318±0.07 0.392±0.14 0.552±0.04 0.583±0.15
60 0.546±0.09 0.550±0.07 0.619±0.06 0.834±0.11
80 0.567±0.11 0.605±0.2 0.675±0.13 0.846±0.08
100 0.612±0.17 0.668±0.03 0.684±0.01 0.945±0.07
AU: Antiradical unit, ABTS: 2,2’-azino-bis (3-ethylbenzothiazoline-6-sulfonic 
acid), DPPH: 2,2-diphenyl-1-picryl-hydrazyl-hydrate, EGB761: Extract of Gingko 
biloba, GBME: EGB761 loaded microemulsion
Table 2: IC50 value of EGB761 and GBME against DPPH and ABTS 
assay
AU IC50 value of EGB761  
(µg/ml)
IC50 value of GBME  
(µg/ml)
DPPH assay ABTS assay DPPH assay ABTS assay
31.1±0.81 47.10±0.32 12.8±0.55 29.6±0.03
AU: Antiradical unit, ABTS: 2,2’-azino-bis (3-ethylbenzothiazoline-6-sulfonic 
acid), DPPH: 2,2-diphenyl-1-picryl-hydrazyl-hydrate, EGB761: Extract of Gingko 
biloba, GBME: EGB761 loaded microemulsion
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EGB761 extract significantly. Vicentini et al., 2011, have also shown that 
the ME system increases stability. Their formulation had quercetin in w/o 
ME with span80 (surfactant), tween 80 (cosurfactant) and canola oil as 
an external phase. Evaluation of AO of the formulation after 12 months 
indicated that the functional groups were retained. In this study, also the 
quantity assessment results of flavonone groups (quercetin, kaempferol, 
and isorhamnetin) present reflected that the GBME formulation 
was quite stable with no significant alteration in its therapeutically 
essential groups of phytocompounds as HPLC analysis of freshly made 
GBME showed concentration of 0.54±0.002 µg, 0.24±0.011 µg, and 
0.12±0.084 µg (Fig. 5a) for quercetin, kaempferol, and isorhamnetine, 
respectively. Whereas, the stored samples (12 months) showed the 
retention of 0.47±0.026 µg (quercetin), 0.21±0.005 µg (kæmpferol), and 
0.10±0.061 µg (isorhamnetin) of the analyzed compounds, suggesting 
very negligible loss of the groups (Fig. 5b). Therefore, it can be concluded 
from the above results that the encapsulation of EGB761 extract in ME 
system has also enhanced its shelf life with respect to its important 
therapeutic compounds intact (Table 3).
Statistical analysis
The obtained result data were expressed by calculating mean of all 
experiments done in triplicates±standard error along with calculation 
of data significance at p<0.01 by one-way ANOVA (50).
CONCLUSION
This study was conducted to evaluate if the developed formulation 
of EGB671 (G. biloba extract) could retain its therapeutic index with 
enhanced shelf life as the most effective therapeutic phytocompounds 
of EGB671 extract, flavone glycosides (quercetin, kaempferol, and 
isohamnetin) are reported to get degraded and metabolized in the gut, 
if taken orally in conventional form. G. biloba is a very important plant 
for treating nervous disorders, and there are many research groups 
working on to improve its therapeutic index and stability by various 
methods. We had developed a ME system earlier, and in this study, 
we have evaluated if we could achieve the aims as mentioned above. 
From this study, we can conclude that the AO and stability efficiency 
of EGB761 extract has enhanced after formulating it into ME system 
(GBME). Collectively, the experimental results suggested that the GBME 
formulation can effectively scavenge ROS and could provide effective 
protection against oxidative damage. The said ME were found to be 
equally efficient (in fact slightly more) in exhibiting their AO activity 
which might have been enhanced due to the already existing intrinsic 
activity of the carrier system components (ME). Furthermore, the 
major constituents of the extract were also found to be almost constant 
after 12 months storage at room temperature. Besides this, the amount 
and ratios of excipients (oil, surfactants and cosurfactants) used for the 
formulation of ME are listed and are under the GRAS limits and that 
may be the reason that formulation was found to be quite safe with 
the toxicity studies. The stability and shelf life of the formulation was 
also augmented in comparison to the pure extract. Thus, the developed 
ME of EGB761 extract could serve as a potential and effective delivery 
system and further can be analyzed in vitro and in vivo for its therapeutic 
index and safety.
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